Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP · NASDAQ Capital Market
-$0.24 today
Vol 0.43M · Avg 0.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-62.89%
Period High
$61.57
Period Low
$10.65
Latest
$12.01
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Forte Biosciences, Inc.
NASDAQ:FBRX
$248.69M
Fate Therapeutics, Inc.
NASDAQ:FATE
$230.20M
Eledon Pharmaceuticals, Inc.
NASDAQ:ELDN
$228.71M
Nkarta, Inc.
NASDAQ:NKTX
$195.32M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$170.60M
Innate Pharma S.A.
NASDAQ:IPHA
$169.96M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$111.66M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$71.00M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$62.56M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest TNXP filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does TNXP have?
Intrinsic Alpha currently shows 20 recent filings for TNXP.
Explore More
Continue the stock analysis
Jump to another research area for this company.